Identifiable Intangible Assets and Goodwill - Indefinite-lived Intangible Assets Percentage of Total Intangibles (Details)	Jun. 28, 2015
Trade Names [Member] | Global Innovative Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	0.00%
Trade Names [Member] | Global Vaccines, Oncology and Consumer Healthcare [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	69.00%
Trade Names [Member] | Global Established Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	31.00%
In Process Research and Development [Member] | Global Innovative Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	7.00%
In Process Research and Development [Member] | Global Vaccines, Oncology and Consumer Healthcare [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	38.00%
In Process Research and Development [Member] | Global Established Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	55.00%